Department Cardiovascular Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages Chinese, English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Specialties & Treatments

Treatment & Services

  • Biventricular Pacemaker
  • Cardiac Oncology
  • Cardio-Oncology Center
  • Cardiovascular Medicine Department
  • George M & Linda H Kaufman Center for Heart Failure
  • Heart Failure Section
  • Heart Transplantation
  • Pericardial Diseases Center
  • Ventricular Assist Device
View all 9 Treatment & Services +

Specialty in Diseases & Conditions

  • Amyloidosis
  • Arrhythmogenic Right Ventricular Dysplasia
  • Cancer Heart Disease
  • Cardiac transplant
  • Cardiomyopathy
  • Cardiorenal Syndrome
  • Dilated Cardiomyopathy
  • Fabry's Disease
  • Familial Cardiomyopathy
  • Family History Of Heart Disease
  • Heart Disease
  • Heart Failure
  • Hypertrophic Cardiomyopathy
  • Infiltrative Cardiomyopathy
  • Ischemic Cardiomyopathy
  • Pulmonary Hypertension
  • Restrictive Cardiomyopathy
  • Sarcoid Heart Disease
View all 18 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About W.H. Wilson Tang, MD

W. H. Wilson Tang, MD, is Director of Cleveland Clinic’s Center for Clinical Genomics; Research Director, and  staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute at the Cleveland Clinic; and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.  As Director of the Cardiomyopathy program, Dr. Tang’s specialty interests include cardiomyopathy, heart failure, heart transplantation and mechanical circulatory assist devices.

Dr. Tang graduated magna cum laude with a Bachelor of Science degree in neural sciences from Brown University in Rhode Island, where he received an honorary one-year period of study of the natural sciences at Jesus College, Cambridge University, in England. Dr. Tang received his medical degree from Harvard Medical School, and completed his internship and residency in internal medicine and a research fellowship in heart failure at Stanford University Medical Center. This was followed by clinical cardiology fellowship training at the Cleveland Clinic, and an advanced clinical fellowship in heart failure and cardiac transplantation. He was appointed to Cleveland Clinic in 2004 as a Staff Physician in the Section of Heart Failure and Cardiac Transplantation Medicine. He is board-certified in internal medicine, cardiovascular medicine, and advanced heart failure and transplant cardiology. Dr. Tang is a Fellow of the American College of Cardiology (ACC) and a Fellow of the American Heart Association (AHA), and has committee appointments in the Heart Failure Society of America (HFSA). He serves as member of the writing committee for both ACC/AHA and HFSA clinical guidelines in the management of heart failure.  He is also a member of the International Society of Heart and Lung Transplantation.

Dr. Tang is a clinician-scientist interested in clinical translational research, with joint appointments with the Department of Cell Biology and the Genomic Medicine Institute at Cleveland Clinic's Lerner Research Institute.  His research has been funded by grants from American Heart Association, American College of Cardiology, and the National Institutes of Health (NIH).  He leads the Cleveland GeneBank Study as well as the Cleveland Heart and Metabolic Prevention Study (CHAMPS) to investigate novel mechanisms in the development of heart diseases.  Dr. Tang also has leadership roles in the NIH-sponsored Clinical and Translational Sciences Collaborative, particularly in the operations of the Clinical Research Unit Services and the Pilot Grant Program.  Dr. Tang’s current research interests include the role of nitrative stress and counter-regulatory mechanisms in the development and progression of heart failure, integrative genomics and metabolomics in cardiomyopathy, cardio-renal physiology, and device-based treatment and remote monitoring in heart failure disease management.  Dr. Tang is currently the Principal Investigator for the Cleveland Heart Failure Network as part of the National Heart Failure Clinical Research Network for translational clinical trials.  Dr. Tang also serves as the Associate Director for Heart Failure Trials of C5Research, the academic research organization for the coordination of multicenter clinical trials.  In 2013, he was elected as member of the American Society of Clinical Investigation, a national honor society for physician scientists for his contributions in heart failure and cardiovascular research.

Dr. Tang has authored over 350 published peer-reviewed manuscripts in medical and scientific journals as well as chapters in medical textbooks. He serves in the Editorial Boards for Journal of the American College of Cardiology Heart Failure, Circulation Heart Failure, American Heart Journal.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Cleveland Clinic
Cardiology, Heart Failure Transplantation
Cleveland, OH USA

Fellowship - Cleveland Clinic
Cleveland, OH USA

Fellowship - Stanford University School of Medicine
Cardiovascular Medicine
Stanford, CA USA

Residency - Stanford University Medical Center
Internal Medicine
Palo Alto, CA USA

Internship - Stanford University Medical Center
Internal Medicine
Palo Alto, CA USA

Medical School - Harvard Medical School
Boston, MA USA

Undergraduate - Warren Alpert Medical School of Brown University Rhode Island Hospital
Natural Sciences
Providence, RI USA

Professional Highlights

  • Director, Center for Clinical Genomics, Cleveland Clinic
  • Director, NIH Clinical and Translational Sciences Collaborative Clinical Research Unit, Cleveland Clinic; Co-Director, Pilot Grant Program.
  • Chair, Research Programs Committee, Cleveland Clinic
  • Associate Director for Heart Failure Trials, Cleveland Clinic Coordinating Center for Clinical Research (C5Research)
  • Medical Director, Center for Cardiovascular Diagnostics and Prevention, Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic


  • Internal Medicine
  • Internal Medicine - Cardiovascular Disease
  • Internal Medicine - Advanced Heart Failure and Transplant Cardiology

Specialty Interests

Cardiomyopathy, heart failure, heart transplantation, ventricular assist device, myocardial biopsy, cardiac catheterization, cancer heart disease, amyloidosis, cardiorenal syndrome, inherited cardiovascular diseases

Awards & Honors

  • Fellow, American College of Cardiology
  • Fellow, American Heart Association
  • Research funding from National Institutes of Health, American Heart Association and American College of Cardiology Foundation


  • American College of Cardiology
  • American Heart Association
  • Heart Failure Society of America
  • International Society of Heart and Lung Transplantation
  • American College of Physicians
Research & Publications

Research & Publications

See publications for W.H. Wilson Tang, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/7/2016, Dr. Tang has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Tang receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Horizon CME, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

67 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.9 out of 5
Explains 4.9
Listens 4.9
Courtesy, Respect & Concern 5
Knows Medical History 5
Time Spent with Patient 5
Patient Rating of Doctor 4.9

2 Patient Comments

Reviewed on Dec 28, 2016

Dr Tang is my personal hero and has saved my life.

Reviewed on Jul 19, 2016


Related Videos Featuring W.H. Wilson Tang, MD